Zacharon Pharmaceuticals Inc.
Zacharon Pharmaceuticals, Inc. is a biotechnology company founded on opportunities to discover first-in-class small molecule drugs that target glycans. Zacharon was incorporated in 2004 and has received funding through NIH grants, individual investors, and a recent Series A financing provided by Avalon Ventures LLC, a long-standing San Diego-based venture capital firm with a focus on early stage life science companies. With this strong financial backing in place, Zacharon has the potential to dominate the field of glycan-targeted drug discovery.
